Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dyadic International (DYAI)

Dyadic International (DYAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dyadic International Receives $3 Million Grant from Gates Foundation for Monoclonal Antibody Development Targeting RSV and Malaria

Dyadic International received a $3 million Gates Foundation grant for developing monoclonal antibodies targeting RSV and malaria.Quiver AI SummaryDyadic International, Inc., a biotechnology company, has...

DYAI : 1.7500 (-8.14%)
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

DYAI : 1.7500 (-8.14%)
Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

DYAI : 1.7500 (-8.14%)
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

DYAI : 1.7500 (-8.14%)
Dyadic Expands Global Presence with Participation in Key Industry Events

DYAI : 1.7500 (-8.14%)
Dyadic International, Inc Invites You to Join Us at The Microcap Conference

Jupiter, Florida--(Newsfile Corp. - January 22, 2024) - Dyadic International, Inc (NASDAQ: DYAI), Dyadic International, Inc. is a global biotechnology company focused on building innovative microbial platforms...

DYAI : 1.7500 (-8.14%)
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments

Submission of a Clinical Trial Application (CTA) with South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 study to support...

DYAI : 1.7500 (-8.14%)
Dyadic to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022

JUPITER, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global...

DYAI : 1.7500 (-8.14%)
Dyadic to Participate in Bio-Manufacturing Innovation Summit and NIIMBL National Meeting

JUPITER, Fla., July 05, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...

DYAI : 1.7500 (-8.14%)
Dyadic to Participate in Three Upcoming Industry Events

JUPITER, Fla., June 09, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...

DYAI : 1.7500 (-8.14%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar